Children with oligoarticular Juvenile Idiopathic Arthritis have skewed synovial monocyte polarization pattern with functional impairment – a distinct inflammatory pattern for oligoarticular juvenile arthritis

doi:10.21203/rs.3.rs-29879/v1

Download PDF

Research article

Children with oligoarticular Juvenile Idiopathic Arthritis have skewed synovial monocyte polarization pattern with functional impairment – a distinct inflammatory pattern for oligoarticular juvenile arthritis

https://doi.org/10.21203/rs.3.rs-29879/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 12 Aug, 2020

Read the published version in Arthritis Research & Therapy →

You are reading this older preprint version

Read the latest preprint version →

Background

Juvenile idiopathic arthritis (JIA) is an umbrella term of inflammatory joint diseases in children. Oligoarthritis is the most common form in the Western world, representing roughly 60% of all patients. Monocytes and macrophages play an important role in adult arthritides, but their role in oligoarticular JIA is less studied. Polarization highly influences monocytes’ and macrophages’ effector functions, broadly separated into pro-inflammatory M1 or anti-inflammatory M2 phenotypes. Here, we set out to investigate the polarization pattern and functional aspects of synovial monocytes in oligoarticular juvenile idiopathic arthritis (JIA).

Methods

Paired synovial fluid, blood samples (n = 13) and synovial biopsies (n = 3) were collected from patients with untreated oligoarticular JIA. Monocytes were analyzed for polarization markers by flow cytometry and qPCR. Effector function was analyzed by a phagocytosis assay. Polarization of healthy monocytes was investigated by stimulation with synovial fluid in vitro. Monocyte/macrophage distribution, polarization and mRNA expression were investigated in biopsies by immunohistochemistry, immunofluorescence and in situ hybridization.

Results

Children with oligoarticular JIA have polarized synovial fluid monocytes of a specific M1(IFNg)/M2(IL-4)-like pattern. This was evidenced by increased surface expression of CD40 (p < 0.001), CD86 (p < 0.001) and CD206 (p < 0.001), but not CD163, as compared to paired circulating monocytes, and extensively explored at the mRNA level were synovial fluid monocytes differentially expressed classical markers of M1(IFNg)/M2(IL-4) polarization. Synovial fluid monocytes were functionally affected, as assessed by reduced capacity to phagocytose (p < 0.01). Synovial fluid induced M2 (CD16 and CD206), but not M1 (CD40 and CD86) markers in healthy monocytes and did not induce cytokine production. Single and co-expression of surface CD40 and CD206, as well as mRNA expression of IL-10 and TNF, was observed in monocytes/macrophages in synovial biopsies.

Conclusion

Children with untreated oligoarticular JIA have similar and distinct synovial fluid monocyte polarization pattern of mixed pro- and anti-inflammatory features. This pattern was not exclusively a result of the synovial fluid milieu as monocytes/macrophages in the synovial membrane show similar patterns. Our study highlights a distinct polarization pattern in oligoarticular JIA, which could be utilized for future treatment strategies.

Pediatrics

Rheumatology

Juvenile Idiopathic Arthritis

monocytes

polarization

inflammation

synovitis

Juvenile Idiopathic Arthritis (JIA) is a heterogenous inflammatory disease mainly affecting the joints. JIA is an umbrella description of arthritides persisting longer than six weeks with unknown etiology in patients below 16 years of age (1). The international league of associations for rheumatology (ILAR) recognizes seven categories of JIA (2). Oligoarticular JIA is the most common subgroup, affecting 50–80% of JIA patients and involve fewer (≤4) and mainly larger joints at presentation (3, 4). The majority of these patients have auto-antibodies against nuclear components (ANA), but lack rheumatoid factor (RF) (3). These children are typically of preschool age when disease develops (3). Adult counterparts exist for all JIA subgroups except for the oligoarticular subgroup; thus, these children seem to have a specific childhood onset arthritis, separate from adult arthritides.

The pathogenesis of JIA is mostly unknown. The synovium is exposed to infiltration of leukocytes, hyperplasia and long-lasting inflammation. Amongst the infiltrating cells are monocytes, which are plastic and heterogenous cells categorized based on CD14 and CD16 surface expression into ‘classical’ (CD14⁺CD16⁻), ‘intermediate’ (CD14⁺CD16⁺) and ‘alternative’ (CD14⁻CD16⁺) subtypes (5). ‘Classical’ monocytes are the most prevalent, representing approximately 80–90% of the circulating monocytes under healthy conditions. In arthritis, monocytes are also found within synovial fluid and tissue where they demonstrate clear differences to their circulating counterparts, e.g. by increased CD16 expression (6).

Monocytes and macrophages are highly influenced by the surrounding environment, which may polarize – or activate – these cells, resulting in specialized effector functions. This polarization process traditionally separates them in vitro into pro-inflammatory M1 or anti-inflammatory M2 phenotypes (7, 8). In vitro, monocyte- or macrophage phenotypes are induced by various cytokine cocktails. The M1 phenotype is usually induced with IFNg and/or LPS, whilst the M2 phenotype is achieved using IL-4 or IL-10. Here, we refer to these phenotypes as M1(IFNg), M2(IL-4) and M2(IL-10), respectively, as end points of polarization (7, 9). However, it is important to remember that this classification is, amongst others, a mere in vitro simplification, and represents only endpoints in a continuum of polarization. M1(IFNg) monocytes have an increased surface expression of CD40 and CD80, and produce pro-inflammatory cytokines, such as IL-1b and TNF (7, 9). These cells have also been shown to have decreased Fc-mediated phagocytosis (10). In contrast, M2(IL-4) monocytes express high levels of CD206, TGM2 and PPAR𝛾 (11). They produce anti-inflammatory cytokines, including TGF-b and IL-10. Finally, M2(IL-10) are highly phagocytic and efferocytic, expressing CD163, as well as CD16 and HO-1 (12).

Monocytes simultaneously showing M1- and M2-like properties are identified in vivo, seemingly highly context dependent. Polarization is believed to influence disease by affecting effector functions (13). For example, IL-10 positive M2(IL-10)-like macrophages have been found in the lining layer of the synovium in rheumatoid arthritis (RA) and, more prominently, in spondylarthritis (SpA), whilst the sub-lining layers consisted more of a heterogenous M1/M2-like pattern (14). Stimulation of monocyte-derived macrophages with synovial fluid from patients with SpA induced a higher expression of M2 markers CD163 and CD200R1 than synovial fluid from patients with RA (15). Circulating and synovial intermediate CD14⁺CD16⁺ monocytes are expanded in enthesitis-related JIA, where synovial monocytes display a M2(IL-10)-like pattern (16, 17). Thus, M2(IL-10) polarization patterns have been associated with arthritides. Nevertheless, the precise role of M1/M2 monocytes and macrophages in arthritis remains to be identified and to our knowledge, there has been no studies thoroughly investigating the polarization of monocytes in oligoarticular JIA.

Here, we aimed to map the polarization state of synovial monocytes and macrophages in oligoarticular JIA. We speculated that monocytes voyaging from the circulation to the synovium polarizes in both the inflamed tissue and synovial fluid, and contribute to the pathogenesis through cytokine production, cell-cell interactions and reduced phagocytosis.

Patient data, materials and sample collection

Patients with oligoarticular JIA without any antirheumatic medications with active disease undergoing therapeutic joint aspiration at the Department of Pediatrics, section for Pediatric Rheumatology, between 2016 to 2019, were included in the study. As patients routinely are prescribed pain killers, including non-steroid anti-inflammatory drugs (NSAIDs) by the primary care, these drugs were not considered as treatment of JIA. In total, 16 patients were included in this study. Two patients were later found to have another diagnosis or subclassification, and were thus excluded from the analysis. Blood (n = 13) and synovial fluid (n = 13) samples were collected. When possible, synovial biopsies (n = 3) were taken by an ultrasound guided technique as previously described (18). Details on biopsy handling are found in supplementary material. Details on sample handling are found in supplementary methods. Patient data and performed analyses on specific patients can be found in Table 1. This study was approved by the Regional Ethical Review Board for southern Sweden (LU2016/128 and LU2017/473). Informed consent was obtained from the patients and the patient’s guardians.

Table 1

Clinical data and sample information of the included patients.
	Sex M/F	Disease duration (months)	Age⁺ (years)	Treat-ment	Uveitis	ANA	SF/ plasma	Biopsy	Cytokine Assay SF/plasma	Phago- cytosis
1	F	0	6	NSAID	Yes	Pos	Y/N	Yes	Y/N	Yes
2	F	3	11	No	Yes	Pos	Y/Y	No	Y/Y	Yes
3	F	2	3.5	No	No	Pos	Y/Y	Yes	Y/Y	Yes
4	M	1	12	NSAID	No	Neg	Y/Y	No	Y/Y	Yes
5	F	1	13	NSAID	No	Neg	Y/Y	No	Y/Y	Yes
6	F	1	15	NSAID	No	Pos	Y/Y	No	Y/Y	Yes
7	F	0	2	No	No	Pos	Y/Y	No	Y/Y	Yes
8	F	1	11	No	No	Neg	N/N	Yes	N/N	No
9	F	72^§	8	No	No	Pos	Y/N	No	Y/N	Yes
10	F	120*	12.5	NSAID	No	Pos	Y/N	No	Y/N	No
11	F	49*	7.5	NSAID	No	Pos	Y/N	No	Y/N	Yes
12	M	132*	6	No	No	Pos	Y/Y	No	Y/Y	No
13	F	48*	16.5	No	Yes	Pos	Y/Y	No	Y/Y	Yes
14	F	88*	11	NSAID	No	Pos	Y/Y	No	Y/Y	Yes
*has been in long term remission off treatment. ^§has been in remission on medication. ⁺ Age at sample. Ext- Extended oJIA. M/F- Male/Female. N/A - No data. Y – Yes. N – No. Mtx- Methotrexate

Sample preparation and isolation of monocytes

Synovial fluid cells were isolated by centrifugation (500 g, 10 min), resuspended in PBS, counted and adjusted to a concentration of 1 × 10⁶ cells/ml to be analyzed by flow cytometry (see below). In parallel, monocytes were isolated from blood (n = 5) and synovial fluid (n = 9) for RNA extraction. Details on monocyte isolation can be found in supplementary methods. Monocyte purity was assessed by flow cytometry and contaminating cells were consistently < 5%.

Flow cytometry

Synovial fluid-derived cells and whole blood were analyzed by a panel of nine surface markers. Whole blood or PBS resuspended synovial fluid-derived cells were incubated with the following antibodies against specific markers: CD3, CD14, CD16, CD19, CD40, CD56, CD86, CD163 and CD206. The clones and fluorophores are found in supplementary methods. All antibodies were obtained from BD Biosciences, except CD14 that was obtained from BioLegend (used in 1:50 dilution in PBS for anti-human CD3 and anti-human CD19, 1:200 dilution for the rest). PBS was used as a negative control. In vitro defined polarization markers were confirmed to be differentially expressed by polarized monocytes from healthy individuals using cytokine cocktails as described previously (supplementary Fig. 1) (12). Incubated blood was lysed (TQ-prep with Immunoprep reagent system, Beckman Coulter). Cells were analyzed by the BD FacsCANTO II flow cytometer (BD Biosciences) and BD FacsDiva Software (Version 8, BD Biosciences). Paired blood samples were used to set gates for the synovial monocytes. Gating strategy applied can be found in supplementary Fig. 2.

Quantitative RT-PCR

Total RNA was extracted from monocytes isolated from synovial fluid- and circulating monocytes by the RNeasy Mini Kit (Qiagen). RNA quantity was determined by a NanoDrop 1000 (Thermo Scientific). Isolated RNA was stored at -80 °C until use. 250 ng of total RNA was converted to cDNA using the RT² First Strand Kit (Qiagen). A Custom RT² Profiler PCR Array (Qiagen) was designed containing 28 M1 or M2 related genes (supplementary table 1) and analyzed according to the manufacturer’s instructions using the StepOnePlus real-time PCR system (Applied Biosystems). Ct values were extracted, normalized to the geometric mean of three housekeeping genes (beta-2-microglubilin, b actin and cyclophilin A) and analyzed by the ∆∆Ct method. In patients where RNA from circulating monocytes was not available, the Ct values of their synovial fluid monocytes were normalized and compared to the geometric means of those patients where RNA from circulating monocytes were collected.

Phagocytosis and ROS production

Phagocytosis and ROS production was assessed by PhagoTest™ and PhagoBurst™ (BD Biosciences), respectively, according the manufacturer’s instructions. Stimulation of phagocytosis was performed using opsonized E. Coli and ROS production using PMA. Heparinized whole blood and uncentrifuged synovial fluid were used for analyses on a BD FacsCANTO II.

Culture and polarization of monocytes

The ability of synovial fluid to induce polarization was investigated by stimulation of cultured monocytes. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood of healthy volunteers using LymphoPrep. Monocytes were further extracted using magnetic CD14 microbeads and MACS LS columns (Miltenyi). Cells were cultured in RPMI 1640 medium supplemented with 2.05 mM L-Glutamine (Gibco Life Technologies) and 10% normal human serum (Sigma-Aldrich) overnight at 37 °C, 5% CO₂. Next day, medium was replaced with fresh medium containing 10% synovial fluid or 10% plasma. Clotting of plasma was performed by incubation with 3 mM CaCl₂ and 5 mM MgCl₂ for 1hr at 37 °C, before addition to the medium. Cells were cultured for 48hrs before collection by application of ice-cold PBS/0.5 mM EDTA buffer and careful pipetting. The cells were analyzed for CD16, CD163, CD40, PDL1, CD86 and CD206. Details on clones and fluorophores are found in supplementary methods. All antibodies were diluted 1:100. Some patients lacked paired plasma samples. In these patients, the values of the synovial fluid polarized monocytes were compared to the median of the MFI values from plasma induced monocytes. Statistics were calculated only in paired samples. BD FACS Canto II and BD FacsDiva was used for analysis.

Cytokine production by in vitro polarized monocytes

Monocytes from healthy donors were isolated as described above and cultured overnight. Next day, medium was replaced with fresh medium containing 1 µλ/ml BD GolgiPlug (BD Biosciences) and supplemented with 20% synovial fluid (n = 13) or 20% clotted plasma (see above) from healthy donors (n = 3). LPS (1 ng/ml, Invivogen) was used as a positive control. Cells were cultured for 6hrs, detached and fixated using BD fixation/permeabilization kit according the manufacturer’s instructions. Cells were then analyzed for anti-TNF PE (MAb11), anti-IL-6 BV421 (MQ2-13A5), anti-IL-8 Alexa fluor 488 (E8N1) and anti-IL-10 APC (JES3-18F1) (all from BD), diluted 1:100. Cells were analyzed using BD FacsCANTO II and the BD FacsDiva Software.

Cytometric bead array

Cytokine levels in synovial fluid (n = 13) and plasma (n = 9) was measured using the cytometric bead array (CBA) enhanced sensitivity flex set including nine cytokines (IL-1B, IL-4, IL-6, IL-8, IL-10, IL17A, IL-17F, IFN𝛾 and TNF, BD Biosciences) according to the manufacturer’s instructions. Plasma and synovial fluid samples were diluted 1:3 in dilution buffer. Samples were analyzed by BD FacsCANTO II. The cytokine concentrations were determined using standards and the FCAP software (BD Biosciences).

Immunohistochemistry

Slides were baked at 60 °C for 1hr before deparaffinization and rehydration using xylene and a decaying ethanol series. Dako EnVision + System-HRP (DAB) Kit (Agilent/Dako) was utilized for signal detection. Following rehydration and blocking of peroxidase activity, the slides were blocked using 5% BSA/PBS for 30 min. Slides were washed in PBS and incubated with 1:500 diluted mouse anti-human CD163 (clone: EDHu-1), 1:2000 with mouse anti-human CD14 (clone: 1H5D8) or 1:250 mouse anti-human CD68 (clone: Y1/82A) in 2% BSA/PBS overnight at 4 °C. Slides were then washed, dehydrated and mounted using Pertex Mounting Medium (HistoLab). Images were gathered using a Zeiss Primo Vert microscope (Zeiss) equipped with AxioCam ERc (Zeiss). All antibodies showed similar staining but CD163 provided the least amount of background and was thus used for further analysis.

In situ hybridization

To further investigate the macrophage profile in the synovium, in situ hybridization was used to analyze cytokine mRNA expression in synovial biopsies (19). The RNAscope® 2.5 HD Chromogenic Duplex Assay (Advanced Cell Diagnostics), was performed according to the manufacturer’s instructions. Two different probes were used, targeting TNF (blue) and IL-10 (red). For detailed information see supplementary methods. Images were acquired using Zeiss microscope. Sections stained with one dot or less per ten cells were considered to be negative.

Immunofluorescence

Immunofluorescence was utilized to investigate polarization in synovial tissue using the traditional markers CD40 and CD206. Slides were deparaffinized as described above. Antigen retrieval was performed using citrate buffer pH 6.0 followed by blocking with 5% BSA and 5% donkey serum (Abcam) for 30 min, RT. Slides were next incubated o/n at 4 °C with primary antibodies: 1:250 rabbit anti-human CD163 (clone: EPR19518, Abcam), 1:250 mouse anti-human CD206 (clone:22–130, Antibodies-Online), and 1:100 goat anti-human CD40 (clone:glu21-Arg193, R&D Systems). The following day, slides were washed with PBS and incubated for 1hr at RT with secondary antibodies: (all 1:200, donkey anti-mouse Alexa Fluor 568, donkey anti-rabbit Alexa Fluor 568 and donkey anti-goat Alexa Fluor 647 (all Abcam). Images were acquired using Zeiss microscope.

Statistics

Values are displayed as median and interquartile range (IQR) if not otherwise indicated. Paired samples were analyzed by the Wilcoxon’s matched-pairs signed rank test. Statistical analyses were performed by Prism 7. P < 0.05 was considered statistically significant.

Patient characteristics and data

In total, 14 patients fulfilled the set inclusion criteria; oligoarticular JIA, untreated (with the exception of NSAID) and undergoing a therapeutic arthrocentesis. Patient 1–8 were newly diagnosed whereas patient 9–14 had been diagnosed with oligoarticular JIA previously, but had been in stable remission without treatment for at least six months. Patient data and characteristics are summarized in Table 1. Two additional patients were primary included as they met the inclusion criteria but were later found to have systemic-onset JIA and enthesitis-related JIA, respectively. They were thus excluded from the final compilation, but data from these patients are presented in the supplementary material.

Synovial fluid monocytes from patients with oligoarticular JIA have altered CD14 and CD16 expression compared to circulating monocytes

We first investigated if the distribution of monocyte subsets differs between synovial fluid and paired blood, based on CD14/CD16 expression. We observed a significant decrease in the frequency of CD14⁺CD16⁻ monocytes in synovial fluid compared to blood (median % positive cells): (36.7% vs 88.2%, p < 0.001) with a corresponding increased frequency of intermediate CD14⁺CD16⁺ monocytes (49.8% vs 5.7%, p < 0.001, Fig. 1A-B). There was no significant difference in the frequency of CD14⁻CD16⁺ monocytes. Accordingly, MFI values of both CD14 (20441 vs 7849, p < 0.001) and CD16 (1736 vs 238, p < 0.001) were increased in the monocyte CD14⁺ population in synovial fluid compared to blood (Supplementary Fig. 3A).

Synovial fluid monocytes have increased surface expression of CD40, CD206 and CD86 expression, but not of CD163

To explore synovial fluid monocyte polarization, paired synovial fluid and blood samples were analyzed for multiple surface markers. Synovial fluid monocytes from patients with oligoarticular JIA had increased expression of the M1 marker CD40 (2452 vs 688, p < 0.001), CD86 (6414 vs 3247, p < 0.001) and the M2 marker CD206 (310 vs 88, p < 0.001), as compared to patients’ circulating monocytes (Fig. 1C). CD40 was consequently higher expressed in synovial monocytes but not all synovial fluid monocytes had higher expression of CD206 compared to circulating monocytes. Gating on percentage positive cells, barely 37% (median) of the synovial fluid monocytes expressed CD206, even though the MFI values were markedly increased. The CD206⁺ cells also expressed high levels of CD40 (Supplementary Fig. 3B). Intermediate CD14⁺CD16⁺ displayed higher expression of all markers compared to classical CD14⁺CD16⁻ monocytes (supplementary Fig. 3C). There was no significant difference in the expression of the M2 marker CD163 (235 vs 268). Synovial fluid monocytes from the two patients with systemic-onset JIA and enthesitis-related JIA, respectively, showed increased expression of CD163, as previously described (supplementary Fig. 3D). Thus, synovial fluid monocytes from children with oligoarticular JIA have a surface expression pattern of combined M1(IFNg) and M2(IL-4), but not M2(IL-10).

Synovial fluid monocytes display a similar and specific mixed M1(IFNg)- and M2(IL-4)-like mRNA pattern

To more thoroughly investigate the polarization pattern of synovial monocytes, monocytes were analyzed at the mRNA level for 28 polarization-related genes using qPCR. In accordance with flow cytometry data, synovial fluid monocytes expressed both M1(IFNg)- and M2(IL-4)-related markers, a result showing high similarity across patients (Fig. 2A). In total, 14 out of 28 genes showed a more than 2-fold change in expression compared to circulating monocytes, including cytokines, chemokines, enzymes and transcription factors. M2(IL-10) in vitro defined markers CD163, HO-1 and STAT3, were not differentially expressed between the synovial fluid- and circulating monocytes. Neither were other, well-defined markers of both M1 and M2 polarization, e.g. iNOS and CD200R1, increased in synovial fluid monocytes. Taken together, these data demonstrate a polarization and activation pattern in synovial fluid monocytes that is not exclusively M1- or M2-like. Instead, there is a specific pattern combined of traditional in vitro defined M1(IFNg) (CD80, STAT1 and CXCL10) and M2(IL-4) (CD206, CCL18 and PPARg), but not M2(IL-10) related markers across all patients.

Synovial fluid monocytes have reduced phagocytosis and oxidative burst

Next we sought to determine if synovial fluid monocytes are altered at the functional level, assessing phagocytosis and oxidative burst. Synovial fluid monocytes showed a reduced ability to phagocytose as compared to paired circulating monocytes (MFI; 1082 vs 1462, p < 0.01), Fig. 2B) as well as being less prone to undergo oxidative burst upon stimulation with PMA (MFI; 234 vs 337, p < 0.01, Fig. 2B). This was not an effect of synovial fluid alone, as addition of cell free synovial fluid to whole blood at a 10:1 ratio did not result in altered phagocytosis (data not shown).

Synovial fluid from patients with oligoarticular JIA induces upregulation of some M2-, but not M1-like markers on healthy monocytes

To determine if synovial fluid is responsible for the observed polarization pattern, monocytes from healthy donors were cultured in vitro and polarized using synovial fluid or plasma from JIA patients. Synovial fluid significantly upregulated M2-markers CD16 and CD206 (p < 0.05), but not CD163 (p = 0.2) as compared to plasma polarized monocytes (Fig. 3A). Further, synovial fluid downregulated M1(IFNg)-markers CD40 and CD86 (p < 0.05). Thus, synovial fluid alone did not induce the specific pattern seen in patients’ synovial fluid monocytes.

Synovial fluid did not induce cytokine production in healthy monocytes

To further elucidate the inflammatory role of synovial fluid, cell-free synovial fluid (n = 13) or plasma from healthy controls (n = 3) was used to activate cytokine production in monocytes from healthy donors. Synovial fluid did not induce any production of pro- or anti-inflammatory cytokines TNF, IL-6, IL-8 or IL-10 compared to plasma from healthy donors, whilst LPS clearly induced production of most cytokines (Supplementary Fig. 4).

Cytokine pattern in oligoarticular JIA patients’ synovial fluid

Next, we explored the cytokine environment within synovial fluid (n = 13) considering several inflammatory cytokines: IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-17A, TNF and IFNg (Fig. 3B). We found measurable concentrations (median (IQR) of IL-1b (3.9 pg/ml (2.2–8.9)), IL-6 (1755 pg/ml (646–4038)), IL-8 (1801 pg/ml (941–2696)) and IL-10 (14.6 pg/ml (9.3–23)) in the synovial fluid. Interestingly, traditional cytokines used to induce M1(IFNg) and M2(IL-4), were not present at measurable concentrations in the synovial fluid. Furthermore, we found very low or no measurable levels of IL-12p70, TNF and IL-17A (Supplementary Fig. 5). Concentrations of the respective cytokines were not measurable in plasma.

Macrophages are prominent in the synovial membrane of patients with oligoarticular JIA and show a mixed polarization pattern at both mRNA and surface level

Finally, to explore the polarization of monocytes/macrophages in the synovial tissue of patients with JIA, biopsies (n = 3) were collected and stained for polarization markers and cytokine mRNA. Using immunohistochemistry, macrophages were identified in both the lining and sub-lining region (Fig. 4) of the synovial membrane in all patients. The subsequent sections were stained by in situ hybridization for IL-10 (red dots) and TNF (blue dots) mRNA as IL-10 is traditionally considered to be produced by M2(IL4 and IL10) macrophages and TNF by M1(IFNg) macrophages. Both IL-10 and TNF mRNA can be seen in the lining and the sub-lining region (Fig. 4). Controls to the experiment can be found in supplementary Fig. 6. Finally, both single and co-expression of the markers CD40 and CD206 were seen in monocytes/macrophages using immunofluorescence (Fig. 4). Single channel images are available in grayscale in supplementary Fig. 6A-C. Thus, monocytes/macrophages express a mixed M1/M2 pattern both at surface and mRNA level consistent with the pattern demonstrated in synovial fluid.

In this study we show that children with oligoarticular JIA have a distinct activation- and polarization pattern in synovial fluid monocytes. Monocytes displayed features of a mixed M1(IFNg)M2(IL-4), but not M2(IL-10)-like phenotype, both at the surface and at the mRNA level. Functionally, these cells had reduced phagocytosis compared to circulating monocytes. Synovial fluid alone induced an M2-like pattern compared to paired plasma. The synovial membrane contained dense populations of lining- and sub-lining macrophages, with mixed expression of IL-10, TNF, CD40 and CD206. Thus, polarization occurs both in the synovial tissue and fluid. Taken together, our data indicate important roles for monocytes and macrophages and suggest distinct pattern of immune activation in oligoarticular JIA.

In arthritis, monocytes produce pro-inflammatory cytokines, angiogenetic factors and display increased levels of markers involved in antigen presentation. In this study of children with oligoarticular JIA, we observed an increased frequency of synovial CD14⁺CD16⁺ monocytes. Synovial CD14⁺CD16⁺ monocytes have also been shown to be expanded in rheumatoid arthritis (RA) and osteoarthritis (OA) and to promote both Th1 and Th17 responses in vitro (6, 20). We could see an induction of CD16 in cultured monocytes following polarization with synovial fluid. The synovial fluid contained high levels of IL-10, a potent inducer of CD16 expression in monocytes in vitro (21). Thus, the increased CD16 expression is likely due to the local environment in the synovium and do not reflect specific recruitment of intermediate CD14⁺CD16⁺ monocytes from the circulation.

Polarization alters cellular functions, such as the ability to phagocytose, as well as the inflammatory impact the cells have on their environment. Polarization has been investigated for its importance in several settings, including obesity, cancer and arthritis (13). However, the polarization patterns and its consequences have not been studied in children with oligoarticular JIA. Here, we identified mRNA signatures of both M1(IFNg) and M2(IL-4) in vitro defined markers (8, 11, 22). Indeed, several M1(IFNg)- and M2(IL-4)-related chemokines (e.g. CXCL10/11 and CCL13/18), cytokines (e.g. TNF and IL-10) and receptors (e.g. CD80 and CD206), were upregulated but not other traditional markers (e.g. iNOS and CD200R1). Multiple cytokines and chemokines have previously been shown to be elevated at the protein level in patients with oligoarticular JIA, e.g. CXCL10, IL-6 and IL-8 (23). This is in line with our cytokine analysis, suggesting IL-6 and IL-8 to be the most prominent cytokines in the synovial fluid. Thus, the inflammatory pattern of the children with oligoarticular JIA could not be fitted into a traditional polarization pattern, but should rather be considered to be its own specific one.

Interestingly, we could not detect any increase in CD163 neither on the surface- nor at mRNA level in our oligoarticular JIA patients, but has previously been observed in enthesitis-related JIA (16, 17). In our study, two patients with systemic-onset JIA and enthesitis-related JIA, respectively, were initially included as they presented with oligoarticular disease. In these patients, we observed an increased surface expression of CD163 in synovial fluid monocytes compared to monocytes from oligoarticular patients. In addition, CD163 has been linked to several adult arthritides, including increased expression in RA synovial fluid monocytes, and following stimulation of monocytes-derived macrophages with synovial fluid from SpA patients (15, 24). M2(IL-10) like macrophages correlate with inflammatory features in SpA (25, 26). M1/M2 imbalance has been linked to osteoclasteogenesis in RA, to disease severity in OA, and a mixed expression of CD206/CD163 in circulating monocytes from patients with systemic JIA (27–29). Thus, although an M1/M2 imbalance has been demonstrated in arthritides, the children with oligoarticular JIA in our study show a specific pattern that, at least partly, is distinct from what is described in other forms of adult and juvenile arthritides. This needs further investigations, but might suggest that different pathophysiological mechanisms drive inflammation in oligoarticular JIA.

In addition to having a distinct activation and polarization pattern, our patient group of oligoarticular JIA patients show consistent homogeneity throughout the different experiments. This was regardless of whether the patients were newly diagnosed or had been in stable remission without treatment. Thus, the monocyte/macrophage activation pattern was not dependent on disease duration, but rather on disease presentation. All included patients share a similar presentation of active disease, being either treatment naïve or off treatment for at least six months before inclusion. Out of JIA subgroups, oligoarticular JIA does not have an adult counterpart and a majority of these patients are ANA positive (3). A similar pattern seen in all children strengthen the hypothesis that this form of JIA shares a common pathogenesis.

Synovial fluid from the JIA patients induced a mixed M2(IL-4)/M2(IL-10)-like phenotype in monocytes from healthy individuals even though we did not detect any M2(IL-10)-monocytes in the patients. We could not detect any de novo production of IL-6, IL-8 or IL-10 from monocytes stimulated with synovial fluid, even if these cytokines were found in the synovial fluid (23). Taken together, this indicates that the polarization pattern detected in the patients is not only a result of the inflammatory milieu of the synovial fluid. We therefore hypothesized that the monocytes might attain, at least partly, their polarization pattern when migrating through the synovial tissue. In synovial tissue we identified macrophages/monocytes in both the lining and sub-lining regions, an observation that has been previously seen in RA and SpA (14). Additionally, a general expression of TNF and IL-10 mRNA in macrophage rich areas in synovial biopsies, as well as single and co-expression of CD40 and CD206 in monocytes/macrophages supports the idea that the macrophages/monocytes are polarized, suggesting that M1 (and M2) features can be obtained in the synovial membrane, and not exclusively in the synovial fluid. The macrophages have been shown to produce different levels of pro- and anti-inflammatory mediators in different diseases, and their number correlates to disease activity in RA (14, 30, 31). Although, we did not perform an in dept analysis of the macrophages polarization pattern and are limited by the sample size, our data suggests that macrophages are present and activated within the synovium, with both pro- and anti-inflammatory features, in patients with oligoarticular JIA.

We also investigated if the synovial monocytes were functionally affected with regard to phagocytosis and oxidative burst. We observed a reduced ability of synovial monocytes to phagocytose and to perform oxidative burst by reactive oxygen species (ROS) production in response to PMA. Defective oxidative burst, due to a variation in the ncf1 gene, has been shown to result in an increased severity in T-cell dependent arthritis in animal models, an observation counteracted by specific restoration of ROS production in macrophages (32). Decreased phagocytosis has been associated with M1(IFNg) polarization. Conversely, unpolarized and M2 polarized cells displayed an unaltered or increased phagocytosis (10, 33). These studies suggest that impaired ROS production and phagocytosis by monocytes and macrophages contributes to inflammation. However, more research is needed to elucidate the role of ROS and phagocytosis in oligoarticular JIA.

Limitations to our study include some methodological issues. We were not able to sort different monocyte populations. It would be of interest to sort CD206 positive and negative cells and investigate their mRNA expression and cytokine pattern separately. Additional limitations concern the activity of signaling pathways, i.e. at the protein and phosphorylation level, where the JAK/STAT pathway is not necessarily reflected at the mRNA level. Further research should be conducted regarding the functional role of these cells within the joint as recent studies have suggested a protective role of tissue resident synovial monocytes/macrophages (34). Finally, due to their importance in arthritis, further investigation of the synovial tissue macrophage polarization pattern in a larger sample size is of interest to determine their role in the pathogenesis.

We observed a specific synovial monocyte polarization pattern in children with untreated oligoarticular JIA. The synovial fluid monocytes were functionally affected as shown by reduced phagocytosis and oxidative burst. We could also detect polarized macrophages in the synovial membrane of the children with production of both pro- and anti-inflammatory cytokines. In addition, the children displayed a distinct homology in their monocyte pattern regardless of disease duration, suggesting common pathophysiological mechanisms of arthritis in this patient group. Further studies on these cells and functional implications in the pathogenesis provides an interesting area to explore for future treatments.

ANA anti-nuclear antibodies

IL interleukin

IFN interferon

JIA juvenile idiopathic arthritis

LPS lipopolysaccharide

MFI median fluorescens intensity

NSAID non-steroid anti-inflammatory drug

OA osteoarthritis

PBMC peripheral blood mononuclear cells

RA rheumatoid arthritis

ROS reactive oxygen species

SpA spondylarthritis

TNF tumor necrosis factor alpha

Ethics approval and consent to participate

This study was approved by the Regional Ethical Review Board for southern Sweden (LU2016/128 and LU2017/473). Informed consent was obtained from the patients and the patient’s guardians.

Consent for publication

Not applicable

Availability of data and materials

Anonymized datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors have no financial disclosures or conflicts of interests to declare.

Funding

This study was supported by grants from Crown Princess Lovisa’s Society for Child Care, the Swedish Rheumatism Association, Greta and Johan Kock’s Foundation, the Hedberg Foundation, the Anna-Greta Crafoord Foundation, the Crafoord Foundation, the Swedish Medical Society, the Jerring Foundation, Alfred Österlunds Foundation, Magnus Bergvall Foundation, Thelma Zoega’s foundation, King Gustaf V's 80-year foundation, The Knut and Alice Wallenberg foundation, the Medical Faculty at Lund University and Region Skåne (all to RK).

Author contribution

TS carried out the experiments, interpreted data, and wrote the manuscript.

EB carried out the experiments, interpreted data, and reviewed and revised the manuscript.

SAB, AM and BG carried out the experiments and reviewed and revised the manuscript.

FK and AAB interpreted data, reviewed and revised the manuscript.

BM collected clinical data and samples as well as reviewed and revised the manuscript.

RK conceptualized and designed the study, collected data, interpreted data, and wrote the manuscript.

Acknowledgements

The authors would like to gratefully acknowledge Åsa Pettersson’s support in conducting PhagoTest/PhagoBurst experiments. The authors would also like to humbly acknowledge Elisabeth Bengtsson for assistance in collection of patient material.

Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138–49.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.
Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–78.
Giancane G, Consolaro A, Lanni S, Davi S, Schiappapietra B, Ravelli A. Juvenile Idiopathic Arthritis: Diagnosis and Treatment. Rheumatol Ther. 2016;3(2):187–207.
Stansfield BK, Ingram DA. Clinical significance of monocyte heterogeneity. Clin Transl Med. 2015;4:5.
Yoon BR, Yoo SJ, Choi Y, Chung YH, Kim J, Yoo IS, et al. Functional phenotype of synovial monocytes modulating inflammatory T-cell responses in rheumatoid arthritis (RA). PLoS One. 2014;9(10):e109775.
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–86.
Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20.
Mendoza-Coronel E, Ortega E. Macrophage Polarization Modulates FcgammaR- and CD13-Mediated Phagocytosis and Reactive Oxygen Species Production, Independently of Receptor Membrane Expression. Front Immunol. 2017;8:303.
Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol. 2014;5:614.
Ohlsson SM, Linge CP, Gullstrand B, Lood C, Johansson A, Ohlsson S, et al. Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization. Clin Immunol. 2014;152(1–2):10–9.
Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233(9):6425–40.
Ambarus CA, Noordenbos T, de Hair MJ, Tak PP, Baeten DL. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Res Ther. 2012;14(2):R74.
Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, et al. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 2009;60(4):966–75.
Bhattacharya S, Yadav A, Aggarwal A. Evidence for M2 macrophage activation in patients with enthesitis-related arthritis category of juvenile idiopathic arthritis. Clin Rheumatol. 2019.
Gaur P, Myles A, Misra R, Aggarwal A. Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis. Clin Exp Immunol. 2017;187(2):234–41.
Sitt JC, Griffith JF, Wong P. Ultrasound-guided synovial biopsy. Br J Radiol. 2016;89(1057):20150363.
Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14(1):22–9.
Gomez-Aristizabal A, Gandhi R, Mahomed NN, Marshall KW, Viswanathan S. Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study. Arthritis Research & Therapy. 2019;21.
Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, et al. CD14+,CD16 + blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2002;46(10):2578–86.
Atri C, Guerfali FZ, Laouini D. Role of Human Macrophage Polarization in Inflammation during Infectious Diseases. Int J Mol Sci. 2018;19(6).
de Jager W, Hoppenreijs EP, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis. 2007;66(5):589–98.
Smiljanovic B, Radzikowska A, Kuca-Warnawin E, Kurowska W, Grun JR, Stuhlmuller B, et al. Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint. Ann Rheum Dis. 2018;77(2):300–8.
Baeten D, Demetter P, Cuvelier CA, Kruithof E, Van Damme N, De Vos M, et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol. 2002;196(3):343–50.
Baeten D, Moller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F. Association of CD163 + macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. Arthritis Rheum. 2004;50(5):1611–23.
Macaubas C, Nguyen KD, Peck A, Buckingham J, Deshpande C, Wong E, et al. Alternative activation in systemic juvenile idiopathic arthritis monocytes. Clin Immunol. 2012;142(3):362–72.
Liu BL, Zhang MQ, Zhao JM, Zheng M, Yang H. Imbalance of M1/M2 macrophages is linked to severity level of knee osteoarthritis. Experimental Therapeutic Medicine. 2018;16(6):5009–14.
Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, et al. M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis. Front Immunol. 2017;8:1958.
van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis. 1990;49(11):916–20.
Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther. 2006;8(6):R187.
Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. P Natl Acad Sci USA. 2004;101(34):12646–51.
Schulz D, Severin Y, Zanotelli VRT, Bodenmiller B. In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay. Sci Rep-Uk. 2019;9.
Culemann S, Gruneboom A, Nicolas-Avila JA, Weidner D, Lammle KF, Rothe T, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572(7771):670–5.

Download PDF

Journal Publication

published 12 Aug, 2020

Read the published version in Arthritis Research & Therapy →

Editorial decision: Major revision
22 Jun, 2020
Review #2 received at journal
18 Jun, 2020
Review #1 received at journal
18 Jun, 2020
Reviewer #3 agreed at journal
02 Jun, 2020
Reviewer #2 agreed at journal
31 May, 2020
Reviewers invited by journal
19 May, 2020
Reviewer #1 agreed at journal
19 May, 2020
First submitted to journal
18 May, 2020
Editor assigned by journal
18 May, 2020
Submission checks completed at journal
17 May, 2020
Editor invited by journal
17 May, 2020

You are reading this older preprint version

Read the latest preprint version →

Children with oligoarticular Juvenile Idiopathic Arthritis have skewed synovial monocyte polarization pattern with functional impairment – a distinct inflammatory pattern for oligoarticular juvenile arthritis

Status:

Journal Publication

Version 1

Abstract

Background

Methods

Results

Conclusion

Figures

Introduction

Methods

Patient data, materials and sample collection

Sample preparation and isolation of monocytes

Flow cytometry

Quantitative RT-PCR

Phagocytosis and ROS production

Culture and polarization of monocytes

Cytometric bead array

Immunohistochemistry

Immunofluorescence

Statistics

Results

Patient characteristics and data

Synovial fluid monocytes display a similar and specific mixed M1(IFNg)- and M2(IL-4)-like mRNA pattern

Synovial fluid monocytes have reduced phagocytosis and oxidative burst

Synovial fluid did not induce cytokine production in healthy monocytes

Cytokine pattern in oligoarticular JIA patients’ synovial fluid

Discussion

Conclusion

List Of Abbreviations

Declarations

References

Supplementary Files

Status:

Journal Publication

Version 1